Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 97
- Registration Number
- NCT00160290
- Locations
- 🇪🇸
Site 6, Granada, Spain
🇪🇸Site 2, Barcelona, Spain
🇪🇸Site 5, Huesca, Spain
Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination
- Conditions
- Postmenopause
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-03-12
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 454
- Registration Number
- NCT00160316
- Locations
- 🇷🇴
Site 42, Bucharest, Romania
🇷🇴Site 43, Bucharest, Romania
🇷🇴Site 44, Bucharest, Romania
Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2009-04-01
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 135
- Registration Number
- NCT00145522
- Locations
- 🇮🇹
Site 8, Ancona, Italy
🇮🇹Site 9, Firenze, Italy
🇮🇹Sit 14, Modena, Italy
To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox
- Conditions
- SchizophreniaSchizoaffective Disorder
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00141479
- Locations
- 🇺🇸
Site 1, Wichita, Kansas, United States
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
- Conditions
- Menopause
- Interventions
- Drug: Esterified estrogens 1.25 mg
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 133
- Registration Number
- NCT00141557
- Locations
- 🇺🇸
Site 49, Melbourne, Florida, United States
🇺🇸Site 44, Decatur, Georgia, United States
🇺🇸Site 37, Reno, Nevada, United States
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
- Conditions
- Menopause
- Interventions
- Drug: Esterified estrogens 1.25 mg
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 28
- Registration Number
- NCT00141544
- Locations
- 🇺🇸
Site 57, Mobile, Alabama, United States
🇺🇸Site 78, Clearwater, Florida, United States
🇺🇸Site 65, Cary, North Carolina, United States
Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
- Conditions
- Menopause
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 350
- Registration Number
- NCT00141570
- Locations
- 🇺🇸
Site 41, Medford, Oregon, United States
🇺🇸Site 60, Columbus, Ohio, United States
🇺🇸Site 49, Melbourne, Florida, United States
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
- Conditions
- HypogonadismType 2 Diabetes
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00141492
- Locations
- 🇺🇸
Site 3, Portland, Oregon, United States
🇺🇸Site 22, Salem, Virginia, United States
🇺🇸Site 24, Jersey City, New Jersey, United States
PK Effects of Bifeprunox & Valproate in Bipolar I
- Conditions
- Bipolar I Disorder
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00141505
- Locations
- 🇺🇸
Site 1, Atlanta, Georgia, United States
Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder
- Conditions
- Bipolar DisorderSchizophreniaSchizoaffective Disorder
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00139919
- Locations
- 🇺🇸
Site 1, Orange, California, United States